Molecular Biosystems Inc. Company Profile

15:10 EST 22nd November 2017 | BioPortfolio

Molecular Biosystems, Inc. is a leader in the development, manufacture and sale of ultrasound contrast imaging agents. These contrast agents are used primarily to improve the real-time images ("moving pictures") of organs and body structures, especially the heart, obtained through ultrasound examinations. MBI's products are designed to increase the diagnosticusefulness of ultrasound examinations through enhanced visualization of structures and vasculature, and to reduce the need for diagnostic procedures that may be more expensive, time-consuming, or invasive. MBI is the first and only company to obtain marketing approval from the United States Food and Drug Administration ("FDA") for ultrasound contrast agents, having gained approvals for ALBUNEX-Registered Trademark-_in 1994 and for OPTISON-TM- (the Company's second-generation agent) in 1997. OPTISON, a significant improvement over ALBUNEX in terms of efficacy, is used to detect heart disease by assessing blood flow within the heart chambers and by identifying the location of the chamber borders and the movement of the chamber walls ("cardiac function").


10070 Barnes Canyon Road
San Diego
United States of America


Phone: 619 452 0681

News Articles [542 Associated News Articles listed on BioPortfolio]

T2 Biosystems nets $16.5mm via FOPO

Diagnostics firm T2 Biosystems Inc. netted $16.45mm through the follow-on sale of 4.38mm common shares at $4.

T2 Biosystems nets $18.9mm via FOPO

Diagnostics firm T2 Biosystems Inc. netted $18.9mm through the follow-on sale of 5.03mm common shares (including full exercise of the overallotment) at $4.

Genera Biosystems: Diagnostics Come of Age

In early 2008 Genera Biosystems was floated on the ASX and, despite the current economic environment, the CEO, Allen Bollands is feeling positive about the company’s future. He predicts that a ‘go...

CDC, T2 Biosystems team up on Candida auris testing, monitoring

T2 Biosystems and the CDC entered into a collaboration enabling the CDC to use T2's T2Dx instrument for the testing and monit -More- 

EU OKs bacterial panel from T2 Biosystems

T2 Biosystems' T2Bacteria Panel has been granted CE mark approval by European regulators.  -More- 

TARA Biosystems Taps MyoKardia’s Michael Graziano for CSO Post

Michael Graziano is joining TARA Biosystems to become the New York company’s chief scientific officer. TARA Biosystems is developing “heart-on-a-chip” tissue models that can be used in drug dis...

Frost Sullivan Awards Akonni Biosystems for its Groundbreaking TruDiagnosis® Molecular ...

Click here for the full multimedia experience of this release -  "TruDiagnosis ®offers rapid, reliable multiplexed analysis at a lower overall cost Read more...

Imagion Biosystems closes $A12mm IPO on ASX

Imagion Biosystems Ltd. (cancer detection) grossed $A12mm ($9mm) through its initial public offering on the Australian Securities Exchange of 60mm new shares at $A0.20.

Drugs and Medications [2 Associated Drugs and Medications listed on BioPortfolio]

Nilandron [sanofi-aventis U.S. LLC]

NILANDRON (nilutamide)Tablets

Salsalate [Libertas Pharma, Inc.]

Salsalate Tablets, USP 500 and 750 mgRx Only

PubMed Articles [724 Associated PubMed Articles listed on BioPortfolio]

Front cover.

Contents list.

Back cover.

Cross-Validation of High-Resolution Melting Analysis-Based Genotyping Platform.

Developing genetic and pharmacogenetic panels enhances genetic testing in clinical molecular diagnostics and precision medicine. This study was designed to cross-validate the performance of Canon's mu...

Photoinduced Structural Dynamics of Molecular Systems Mapped by Time-Resolved X-ray Methods.

We review the tremendous advances in ultrafast X-ray science, over the past 15 years, making the best use of new ultrashort X-ray sources including table-top or large-scale facilities. Different compl...

Clinical Trials [1105 Associated Clinical Trials listed on BioPortfolio]

The Application of Ticagrelor Combined With Low Molecular Weight Heparin During PCI

The purpose of this study is to determine ticagrelor combining with low molecular weight heparin is effective and safe during PCI or not.

In Vivo EGFR Molecular Classification

The investigators developed 18F-MPG as a targeted molecular imaging agent for noninvasive and repeatable detecting EGFR-activating mutational status.

Clinical Value of Molecular Genetic Analyzes in Gynecological Malignomas

The aim of the planned research project is to find out the clinical significance of molecular genetic analyzes in gynecological malignomas. In particular, it will be investigated how the k...

Validation of a Molecular Prognostic Test for Eye Melanoma

Up to half of patients with ocular melanoma (also called iris, choroidal or uveal melanoma) develop metastasis. We have found that certain molecular features of the eye tumor can be detect...

LCC-CARIS-01: Molecular Profiling in Gynaecological Cancer

This is a pilot feasibility study assessing the use of a commercial molecular profiling service in the UK's National Health Service (NHS). The impact of knowledge of a patient's molecular ...

Companies [913 Associated Companies listed on BioPortfolio]

Akonni BioSystems

Akonni Biosystems, is a molecular diagnostics (MDx) company that develops, manufactures, and markets integrated molecular diagnostic systems. All of Akonni Biosystems tests are currently for Research...

Kapa Biosystems

Kapa Biosystems is a next-generation life science reagents supplier that employs high-throughput molecular evolution to optimize enzymes for DNA amplification, next-generation DNA...

ExpressOn BioSystems

ExpressOn BioSystems Ltd was founded in 1999 by Peter Estibeiro and Eleanor Barnard to provide access to specialised molecular technologies and to develop a range of effective antisense reagents.

Silicon Biosystems S.p.A.

Silicon Biosystems, with offices in Bologna, Italy, and San Diego, CA, has developed an instrument platform for cell and molecular biology, which can sort, manipulate, and ...

Kapa Biosystems, Inc.

Kapa Biosystems is a life science reagents supplier that employs proprietary, directed evolution technologies to optimize enzymes for PCR, real-time PCR, next generation sequencin...

More Information about "Molecular Biosystems Inc." on BioPortfolio

We have published hundreds of Molecular Biosystems Inc. news stories on BioPortfolio along with dozens of Molecular Biosystems Inc. Clinical Trials and PubMed Articles about Molecular Biosystems Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Molecular Biosystems Inc. Companies in our database. You can also find out about relevant Molecular Biosystems Inc. Drugs and Medications on this site too.

Quick Search

Relevant Topics

Radiology is the branch of medicine that studies imaging of the body; X-ray (basic, angiography, barium swallows), ultrasound, MRI, CT and PET. These imaging techniques can be used to diagnose, but also to treat a range of conditions, by allowing visuali...

Cardiovascular disease (CVD)
Acute Coronary Syndromes (ACS) Blood Cardiovascular Dialysis Hypertension Stent Stroke Vascular Cardiovascular disease (CVD) includes all the diseases of the heart and circulation including coronary heart disease (angina...

Corporate Database Quicklinks

Searches Linking to this Company Record